TY  - GEN
AU  - Vogiatzi,Fotini
AU  - Winterberg,Dorothee
AU  - Lenk,Lennart
AU  - Buchmann,Swantje
AU  - Cario,Gunnar
AU  - Schrappe,Martin
AU  - Peipp,Matthias
AU  - Richter-Pechanska,Paulina
AU  - Kulozik,Andreas E
AU  - Lentes,Jana
AU  - Bergmann,Anke K
AU  - Valerius,Thomas
AU  - Frielitz,Fabian-Simon
AU  - Kellner,Christian
AU  - Schewe,Denis M
TI  - Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia
SN  - 1528-0020
PY  - 2020///0127
KW  - Adolescent
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Child
KW  - Child, Preschool
KW  - Female
KW  - Humans
KW  - Male
KW  - Neoplasm, Residual
KW  - drug therapy
KW  - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Treatment Outcome
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood.2019000904
ER  -